Robert Jones
Stock Analyst at Goldman Sachs
(2.33)
# 2,360
Out of 4,828 analysts
20
Total ratings
61.54%
Success rate
5.74%
Average return
Main Sectors:
Stocks Rated by Robert Jones
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Neutral | $307 → $343 | $180.93 | +89.58% | 2 | Apr 28, 2023 | |
| MCK McKesson | Maintains: Buy | $231 → $257 | $690.25 | -62.77% | 6 | May 7, 2021 | |
| ALHC Alignment Healthcare | Initiates: Neutral | $25 | $15.42 | +62.13% | 1 | Apr 20, 2021 | |
| OSCR Oscar Health | Initiates: Buy | $44 | $17.06 | +157.91% | 1 | Mar 29, 2021 | |
| TDOC Teladoc Health | Initiates: Neutral | $206 | $7.08 | +2,809.60% | 1 | Dec 4, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $13 → $8 | $10.78 | -25.79% | 2 | Jun 5, 2020 | |
| HUM Humana | Initiates: Buy | $510 | $253.35 | +101.30% | 1 | Jun 5, 2020 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $143 → $170 | $141.36 | +20.26% | 3 | Jan 10, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Buy | $44 | $15.91 | +176.56% | 2 | Oct 19, 2018 | |
| HSIC Henry Schein | Downgrades: Neutral | n/a | $68.89 | - | 1 | Apr 24, 2018 |
Align Technology
Apr 28, 2023
Maintains: Neutral
Price Target: $307 → $343
Current: $180.93
Upside: +89.58%
McKesson
May 7, 2021
Maintains: Buy
Price Target: $231 → $257
Current: $690.25
Upside: -62.77%
Alignment Healthcare
Apr 20, 2021
Initiates: Neutral
Price Target: $25
Current: $15.42
Upside: +62.13%
Oscar Health
Mar 29, 2021
Initiates: Buy
Price Target: $44
Current: $17.06
Upside: +157.91%
Teladoc Health
Dec 4, 2020
Initiates: Neutral
Price Target: $206
Current: $7.08
Upside: +2,809.60%
Evolent Health
Jun 5, 2020
Downgrades: Neutral
Price Target: $13 → $8
Current: $10.78
Upside: -25.79%
Humana
Jun 5, 2020
Initiates: Buy
Price Target: $510
Current: $253.35
Upside: +101.30%
Charles River Laboratories International
Jan 10, 2020
Upgrades: Buy
Price Target: $143 → $170
Current: $141.36
Upside: +20.26%
DENTSPLY SIRONA
Oct 19, 2018
Upgrades: Buy
Price Target: $44
Current: $15.91
Upside: +176.56%
Henry Schein
Apr 24, 2018
Downgrades: Neutral
Price Target: n/a
Current: $68.89
Upside: -